Trials / Recruiting
RecruitingNCT07188233
Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With FMR
A Study to Evaluate the Feasibility and Safety of Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With Functional Mitral Regurgitation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- HVR Cardio Oy · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with functional mitral regurgitation classified as moderate to severe (3+) or severe (4+) that are symptomatic (NYHA Class II-IV) will be evaluated for treatment using the CathHELIX Transcatheter Mitral Annuloplasty System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcatheter Mitral Valve Repair | Mitral valve repair with the CathHELIX Transcatheter Mitral Annuloplasty System in subjects with functional Mitral Regurgitation |
Timeline
- Start date
- 2024-11-16
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2025-09-23
- Last updated
- 2025-09-23
Locations
2 sites across 2 countries: Georgia, Lithuania
Source: ClinicalTrials.gov record NCT07188233. Inclusion in this directory is not an endorsement.